Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve 1.Unaudited Financial Result(Standalone) along with Limited Review Report for the First Quarter ended June 30, 2026, To consider, evaluate and if deem fit to approve the proposal for raising of funds by way of issuance via various mode and to transact Other Businesses.